Dentsply wins Astra Tech bidding war; calling all CE reviewers!

Dear DrBicuspid Member,

After months of negotiations and rumors of up to 20 bidders, AstraZeneca has agreed to sell Astra Tech to Dentsply International for $1.8 billion. While the economic recession has put a damper on dental implant sales, will Dentsply's new presence help reverse this trend? Read more in this Restoratives Community breaking news story.

Meanwhile, a study from the National Cancer Institute links the rapid rise in the rate of oropharyngeal cancer among men with an increase in the presence of human papillomavirus. In fact, the number of oropharyngeal cancer cases in U.S. men could rise by nearly 30% over the next 10 years. Click here to read what's fueling what some researchers say is nearly a pandemic.

And in Practice Management Community news, dental product suppliers offering special deals, discounts, and rebates is nothing new. But doing it online, every day, is a growing strategy one start-up company hopes to use to its advantage in the dental market. Read more.

Finally, the DrBicuspid Continuing Education Program is looking for qualified dental professionals to review online CE courses. Each reviewer receives free CE credit based on the number of hours spent evaluating content. To find out how to become part of a highly academic team dedicated to the betterment of education in the dental industry, contact Roger Adams at [email protected].

Page 1 of 116
Next Page